Save The Date: Fourth International Antibody Validation Meeting Announced!


Min Read

In this blog:

  • Mark the 13-15th September 2023 in your diaries!
  • What can you look forward to in the 2023 meeting?
  • We reflect on previous antibody validation meetings

The 4th International Antibody Validation Meeting is returning next year, so mark 13-15th September 2023 in your diaries!

This unique meeting, organised by the University of Bath and supported by CiteAb, brings together advocates, experts and enthusiasts in antibody validation, from academic, pharmaceutical/biotechnology research, and supplier fields.

It will provide a forum for discussions into validation methods, standards and the state of the field, aiming to bring about improvements to antibody validation. Ultimately, good validation can help antibodies to reliably drive progress in biomedical research.

The Fourth International Antibody Validation meeting

This year, we will be reflecting on the progress we have made since 2018 (when the Third International Antibody Validation meeting ran). This COVID-induced delay between meetings has given us the opportunity to look back on developments, further challenges and think about what we can expect in the coming years.

We are thrilled to be extending the length of the meeting. It will now be running for two and a half days between the 13-15th of September 2023. We have also moved to a new space within the University of Bath!

This means there will be more opportunity to discuss all things antibody validation with delegates from the academic, pharmaceutical and antibody supplier fields, as well as attend even more thought-provoking talks.

We will be introducing a new drinks networking event on the first night, providing another opportunity to meet with people in the field, and catch up with your connections.

The ever-popular meeting dinner will be returning, with the opportunity to socialise with fellow delegates in the beautiful city of Bath. 

This year will feature a fantastic array of speakers. Previous meeting content has covered advances made in antibody validation, toolboxes available to the community, validations on different types of antibodies and for specific applications, and supplier validation initiatives. More content to be included in the coming meeting will be announced soon!  

As in past years, each day we will also hold a discussion forum to enable questions from the audience to be addressed. This is a great opportunity for everyone to get involved and have their say on current challenges and solutions in the field. You can also expect a range of academic posters, with dedicated sessions to browse and discuss the content. 

Dr Andrew Chalmers, CEO of CiteAb and scientific organiser for the Antibody Validation Meeting, commented:

‘We are thrilled to be able to bring the antibody validation meeting back for 2023. Antibody validation is an essential part of accelerating scientific progress, and something we feel passionately about advocating for at CiteAb. What I love about the meeting is the positive attitude, openness and desire from everyone involved to improve antibody validation. I can’t wait to welcome everyone to Bath again!’

Rhys, Rebecca and Alicia from the CiteAb team at a previous Antibody Validation Meeting
Rhys, Rebecca and Alicia from the CiteAb team at a previous Antibody Validation Meeting

How can I get involved?

If you would like to be involved in the meeting as a sponsor, simply drop us an email

We are releasing a limited number of tickets for the meeting. You will be able to purchase a ticket on the Antibody Validation Meeting website in the New Year.

Publishers and media interested in covering the event and attending are also invited to get in touch.

See you there!

We can’t wait to welcome you back to the International Antibody Validation Meeting! Do subscribe to our newsletter to stay up to date with CiteAb news and further information about the meeting.

  • Skye and the CiteAb team
About the author

Join thousands of people who already enjoy the CiteAb newsletter

To keep up to date with the latest developments to our search engine, news from our life science market data analysis and improvements to our citation provision.